PLP1 and myeloid sarcoma: To that end, missense mutations in PLP1 gene have been described in patients with clinical symptoms consistent with an MS diagnosis, such as an amino acid substitution at residue 31 of PLP (L31V) in a female patient with primary progressive MS [14].